AGC Partners Advises Bernoulli on Its Sale to Capsule

AGC Partners is pleased to announce that its client, Bernoulli, has been acquired by Capsule, a leader in medical device integration and non-critical care patient monitoring solutions and a portfolio company of Francisco Partners. With a team led by Hugh Hoffman, AGC Partners acted as sole financial advisor to Bernoulli. The acquisition includes Bernoulli One™, a real-time clinical surveillance solution that gives care teams contextual information on a patient’s condition that can facilitate early intervention, improve patient safety and enable better clinical outcomes. The acquisition grows Capsule Technologies’ leadership position by extending the reach of its clinical platform into additional use cases by adding patient data visualization to the platform’s existing data management and connectivity capabilities.

Client Testimonial:

Throughout Bernoulli's acquisition process—one that is to be critical in supporting and enabling the Company's next phase of growth—we knew we needed a financial advisor that would act as a true business partner. We wanted a team that would help guide us through meetings and narrow down the investor field, while still allowing us to make the decisions that were best for Bernoulli. We chose Hugh Hoffman and AGC Partners because of their expertise in the HCIT sector of the technology industry and like-minded dedication to maintaining Bernoulli's core business values. With the support of AGC Partners, Bernoulli was able to secure a terrific outcome for our investors, shareholders, customers and employees.
Janet Dillione, CEO, Bernoulli

AGC Partners acted as sole financial advisor to Bernoulli in April, 2019